Skip to main content
. Author manuscript; available in PMC: 2013 Jul 6.
Published in final edited form as: Cancer Chemother Pharmacol. 2012 Dec 30;71(3):627–633. doi: 10.1007/s00280-012-2048-y

Table 1.

Demographic information on patients enrolled at two sites for the phase I study of LE-DT

Parameter Number (%)
Gender
    Male 15 (63)
    Female 9 (37)
Age
    Range 43–68
    Median 58
Ethnicity
    Caucasian 18 (75)
    African-American 6 (25)
Prior systemic therapies
    Range 1–7
    Median 2.5
Disease
    GI 14 (58)
        Gastric/esophageal 4
        Colon 3
        Pancreatic 4
        Liver 1
        Other 2
    Breast 2 (8)
    NSCLCa 4 (17)
    Other 4 (17)